SUPN
Supernus Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | +2 | 42.42M | $1.97B | +5 | −3 |
| Q1 2026 | 104 | -3 | 41.20M | $2.13B | +5 | −9 |
| Q4 2025 | 107 | 0 | 43.16M | $2.15B | +1 | — |
| Q3 2025 | 18 | -1 | 27.64M | $1.32B | — | −2 |
| Q2 2025 | 17 | 0 | 22.78M | $717.88M | — | — |
| Q1 2025 | 14 | 0 | 6.75M | $221.22M | — | — |
| Q4 2024 | 14 | 0 | 6.49M | $234.56M | +1 | −1 |
| Q3 2024 | 13 | 0 | 4.54M | $141.67M | +1 | −1 |
| Q2 2024 | 13 | — | 4.27M | $114.18M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 1.69M | — | $45.08M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 1.41M | — | $37.66M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 1.41M | — | $37.66M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 290.80K | — | $7.78M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (passief) | 208.84K | — | $5.59M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 161.33K | — | $4.32M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 142.93K | — | $3.82M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 142.93K | — | $3.82M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Point72 Asset Management ✦ | 136.34K | — | $3.65M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 73.52K | — | $1.97M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 73.52K | — | $1.97M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 48.56K | — | $1.30M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 47.52K | — | $1.27M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 40.68K | — | $1.09M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Wellington Management ✦ | 40.68K | — | $1.09M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 40.68K | — | $1.09M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 40.68K | — | $1.09M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 13.95K | — | $373,269 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 13.95K | — | $373,269 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 11.05K | — | $295,614 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 323 houders, 57.94M aandelen, $2.88B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.